SEC Form 4 · accession 0001179110-17-011996
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2017 | A | 237 | $31.18 | A | 45,613 | D | |
| Common StockF2 | holding | — | — | — | 171,155 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2017 and ending August 31, 2017. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on August 31, 2017.
- F2The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.